Table 2.
Laboratory and biochemical parameters of the retroperitoneal fibrosis patients at the initial diagnosis, post optical medical treatment (OMT), and post endovascular aneurysm repair (EVAR).
| Laboratory values | Groups | Initial (at presentation) | Post-management (at last follow-up) | P-value |
|---|---|---|---|---|
| C-Reactive Protein (CRP), mg/L mean ± SD (range) | Overall | 50.90 ± 81.7 (0.60–281) | 19.90 ± 28.40 (0.80–84.0) | 0.19 |
| EVAR | 47.10 ± 60.80 (4.50–148) | 29.70 ± 34.40 (1.80–84.0) | 0.59 | |
| OMT | 53.20 ± 96.50 (0.60–281) | 14.60 ± 24.80 (0.80–84.0) | 0.26 | |
| White cell count (WCC), 109/L mean ± SD (range) | Overall | 11.14 ± 7.18 (5.10–32.9) | 8.16 ± 3.46 (2.60–15.6) | 0.17 |
| EVAR | 8.28 ± 1.58 (5.10–9.10) | 6.98 ± 1.03 (5.90–8.30) | 0.16 | |
| OMT | 11.70 ± 8.64 (6.10–32.9) | 8.80 ± 4.17 (2.60–15.6) | 0.37 | |
| Neutrophils, 109/L mean ± SD (range) | Overall | 6.72 ± 6.95 (2.20–30.2) | 5.72 ± 2.74 (1.27–11.4) | 0.62 |
| EVAR | 4.16 ± 1.50 (2.20–6.20) | 4.85 ± 1.00 (3.80–6.20) | 0.41 | |
| OMT | 8.14 ± 8.42 (3.90–30.2) | 5.00 ± 3.29 (1.27–11.4) | 0.31 | |
| Eosinophil, 109/L mean ± SD (range) | Overall | 0.29 ± 0.26 (0.00–1.00) | 0.27 ± 0.23 (0.00–1.00) | 0.83 |
| EVAR | 0.28 ± 0.08 (0.20–0.40) | 0.29 ± 0.11 (0.19–0.50) | 0.87 | |
| OMT | 0.30 ± 0.33 (0.00–1.00) | 0.29 ± 0.24 (0.00–1.00) | 0.94 | |
| Estimated glomerular filtration rate (eGFR), ml/min mean ± SD (range) | Overall | 69.50 ± 17.30 (20–90) | 64.40 ± 22.8 (15–90) | 0.51 |
| EVAR | 64.40 ± 28.10 (20–90) | 63.80 ± 30.60 (15–90) | 0.97 | |
| OMT | 72.10 ± 9.65 (55–82) | 64.70 ± 18.60 (32–90) | 0.27 |
EVAR, endovascular aneurysm repair; OMT, optimal medical therapy; SD, standard deviation.